Cargando…
miR-582-5p Is a Tumor Suppressor microRNA Targeting the Hippo-YAP/TAZ Signaling Pathway in Non-Small Cell Lung Cancer
SIMPLE SUMMARY: Lung cancers lead cancer-related mortalities, with Non-Small Cell Lung Cancer (NSCLC) representing a substantial proportion of these cases. Perturbation of Hippo-YAP/TAZ signaling in NSCLC could be mainly attributed to post-transcriptional regulators since genetic alterations to the...
Autores principales: | Zhu, Bowen, V, Mitheera, Finch-Edmondson, Megan, Lee, Yaelim, Wan, Yue, Sudol, Marius, DasGupta, Ramanuj |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918774/ https://www.ncbi.nlm.nih.gov/pubmed/33670427 http://dx.doi.org/10.3390/cancers13040756 |
Ejemplares similares
-
LncRNA SFTA1P mediates positive feedback regulation of the Hippo-YAP/TAZ signaling pathway in non-small cell lung cancer
por: Zhu, Bowen, et al.
Publicado: (2021) -
Common and Unique Transcription Signatures of YAP and TAZ in Gastric Cancer Cells
por: Lee, Yaelim, et al.
Publicado: (2020) -
Pro-Invasive Activity of the Hippo Pathway Effectors YAP and TAZ in Cutaneous
Melanoma
por: Nallet-Staub, Flore, et al.
Publicado: (2014) -
Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018) -
Hippo-Yap/Taz signalling in zebrafish regeneration
por: Riley, Susanna E., et al.
Publicado: (2022)